The impact of structural biology in medicine illustrated with four case studies
The contributions of structural biology to drug discovery have expanded over the last 20 years from structure-based ligand optimization to a broad range of clinically relevant topics including the understanding of disease, target discovery, screening for new types of ligands, discovery of new modes...
Gespeichert in:
| Veröffentlicht in: | Journal of molecular medicine (Berlin, Germany) Germany), 2018, Vol.96 (1), p.9-19 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 19 |
|---|---|
| container_issue | 1 |
| container_start_page | 9 |
| container_title | Journal of molecular medicine (Berlin, Germany) |
| container_volume | 96 |
| creator | Hu, Tiancen Sprague, Elizabeth R. Fodor, Michelle Stams, Travis Clark, Kirk L. Cowan-Jacob, Sandra W. |
| description | The contributions of structural biology to drug discovery have expanded over the last 20 years from structure-based ligand optimization to a broad range of clinically relevant topics including the understanding of disease, target discovery, screening for new types of ligands, discovery of new modes of action, addressing clinical challenges such as side effects or resistance, and providing data to support drug registration. This expansion of scope is due to breakthroughs in the technology, which allow structural information to be obtained rapidly and for more complex molecular systems, but also due to the combination of different technologies such as X-ray, NMR, and other biophysical methods, which allows one to get a more complete molecular understanding of disease and ways to treat it. In this review, we provide examples of the types of impact molecular structure information can have in the clinic for both low molecular weight and biologic drug discovery and describe several case studies from our own work to illustrate some of these contributions. |
| doi_str_mv | 10.1007/s00109-017-1565-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1915557099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1983621658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-6df57a57b3c3e073515fa49fe5ff52e267aeab47d4f6efd756be2ef013cfb8873</originalsourceid><addsrcrecordid>eNp1kM9LwzAUx4Mobk7_AC8S8OKlmqRN0h5l-AsGu8xzSNOXLaNrZ9Li9t-b0SkieHqH9_l-3-OD0DUl95QQ-RAIoaRICJUJ5YInuxM0plnKEppl5BSNSZGJhEkqRugihHWkJS-yczRiuRAFYXKM5osVYLfZatPh1uLQ-d50vdc1Ll1bt8s9dg3eQOWMayJY131EdAcV_nTdCtu299joADHZVw7CJTqzug5wdZwT9P78tJi-JrP5y9v0cZaYVLIuEZXlUnNZpiYFIlNOudVZYYFbyxkwITXoMpNVZgXYSnJRAgNLaGpsmecynaC7oXfr248eQqc2Lhioa91A2wdFC8o5l6QoInr7B13Hr5v4XaTyVDAqeB4pOlDGtyF4sGrr3Ub7vaJEHWyrwbaKEtXBttrFzM2xuS-jo5_Et94IsAEIcdUswf86_W_rF__qi28</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1983621658</pqid></control><display><type>article</type><title>The impact of structural biology in medicine illustrated with four case studies</title><source>Springer Nature - Complete Springer Journals</source><creator>Hu, Tiancen ; Sprague, Elizabeth R. ; Fodor, Michelle ; Stams, Travis ; Clark, Kirk L. ; Cowan-Jacob, Sandra W.</creator><creatorcontrib>Hu, Tiancen ; Sprague, Elizabeth R. ; Fodor, Michelle ; Stams, Travis ; Clark, Kirk L. ; Cowan-Jacob, Sandra W.</creatorcontrib><description>The contributions of structural biology to drug discovery have expanded over the last 20 years from structure-based ligand optimization to a broad range of clinically relevant topics including the understanding of disease, target discovery, screening for new types of ligands, discovery of new modes of action, addressing clinical challenges such as side effects or resistance, and providing data to support drug registration. This expansion of scope is due to breakthroughs in the technology, which allow structural information to be obtained rapidly and for more complex molecular systems, but also due to the combination of different technologies such as X-ray, NMR, and other biophysical methods, which allows one to get a more complete molecular understanding of disease and ways to treat it. In this review, we provide examples of the types of impact molecular structure information can have in the clinic for both low molecular weight and biologic drug discovery and describe several case studies from our own work to illustrate some of these contributions.</description><identifier>ISSN: 0946-2716</identifier><identifier>EISSN: 1432-1440</identifier><identifier>DOI: 10.1007/s00109-017-1565-x</identifier><identifier>PMID: 28669027</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Case studies ; Drug discovery ; Human Genetics ; Internal Medicine ; Low molecular weights ; Molecular Medicine ; Molecular structure ; Molecular weight ; Optimization ; Review ; Side effects</subject><ispartof>Journal of molecular medicine (Berlin, Germany), 2018, Vol.96 (1), p.9-19</ispartof><rights>Springer-Verlag GmbH Germany 2017</rights><rights>Journal of Molecular Medicine is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-6df57a57b3c3e073515fa49fe5ff52e267aeab47d4f6efd756be2ef013cfb8873</citedby><cites>FETCH-LOGICAL-c372t-6df57a57b3c3e073515fa49fe5ff52e267aeab47d4f6efd756be2ef013cfb8873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00109-017-1565-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00109-017-1565-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28669027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Tiancen</creatorcontrib><creatorcontrib>Sprague, Elizabeth R.</creatorcontrib><creatorcontrib>Fodor, Michelle</creatorcontrib><creatorcontrib>Stams, Travis</creatorcontrib><creatorcontrib>Clark, Kirk L.</creatorcontrib><creatorcontrib>Cowan-Jacob, Sandra W.</creatorcontrib><title>The impact of structural biology in medicine illustrated with four case studies</title><title>Journal of molecular medicine (Berlin, Germany)</title><addtitle>J Mol Med</addtitle><addtitle>J Mol Med (Berl)</addtitle><description>The contributions of structural biology to drug discovery have expanded over the last 20 years from structure-based ligand optimization to a broad range of clinically relevant topics including the understanding of disease, target discovery, screening for new types of ligands, discovery of new modes of action, addressing clinical challenges such as side effects or resistance, and providing data to support drug registration. This expansion of scope is due to breakthroughs in the technology, which allow structural information to be obtained rapidly and for more complex molecular systems, but also due to the combination of different technologies such as X-ray, NMR, and other biophysical methods, which allows one to get a more complete molecular understanding of disease and ways to treat it. In this review, we provide examples of the types of impact molecular structure information can have in the clinic for both low molecular weight and biologic drug discovery and describe several case studies from our own work to illustrate some of these contributions.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Case studies</subject><subject>Drug discovery</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Low molecular weights</subject><subject>Molecular Medicine</subject><subject>Molecular structure</subject><subject>Molecular weight</subject><subject>Optimization</subject><subject>Review</subject><subject>Side effects</subject><issn>0946-2716</issn><issn>1432-1440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kM9LwzAUx4Mobk7_AC8S8OKlmqRN0h5l-AsGu8xzSNOXLaNrZ9Li9t-b0SkieHqH9_l-3-OD0DUl95QQ-RAIoaRICJUJ5YInuxM0plnKEppl5BSNSZGJhEkqRugihHWkJS-yczRiuRAFYXKM5osVYLfZatPh1uLQ-d50vdc1Ll1bt8s9dg3eQOWMayJY131EdAcV_nTdCtu299joADHZVw7CJTqzug5wdZwT9P78tJi-JrP5y9v0cZaYVLIuEZXlUnNZpiYFIlNOudVZYYFbyxkwITXoMpNVZgXYSnJRAgNLaGpsmecynaC7oXfr248eQqc2Lhioa91A2wdFC8o5l6QoInr7B13Hr5v4XaTyVDAqeB4pOlDGtyF4sGrr3Ub7vaJEHWyrwbaKEtXBttrFzM2xuS-jo5_Et94IsAEIcdUswf86_W_rF__qi28</recordid><startdate>2018</startdate><enddate>2018</enddate><creator>Hu, Tiancen</creator><creator>Sprague, Elizabeth R.</creator><creator>Fodor, Michelle</creator><creator>Stams, Travis</creator><creator>Clark, Kirk L.</creator><creator>Cowan-Jacob, Sandra W.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2018</creationdate><title>The impact of structural biology in medicine illustrated with four case studies</title><author>Hu, Tiancen ; Sprague, Elizabeth R. ; Fodor, Michelle ; Stams, Travis ; Clark, Kirk L. ; Cowan-Jacob, Sandra W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-6df57a57b3c3e073515fa49fe5ff52e267aeab47d4f6efd756be2ef013cfb8873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Case studies</topic><topic>Drug discovery</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Low molecular weights</topic><topic>Molecular Medicine</topic><topic>Molecular structure</topic><topic>Molecular weight</topic><topic>Optimization</topic><topic>Review</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Tiancen</creatorcontrib><creatorcontrib>Sprague, Elizabeth R.</creatorcontrib><creatorcontrib>Fodor, Michelle</creatorcontrib><creatorcontrib>Stams, Travis</creatorcontrib><creatorcontrib>Clark, Kirk L.</creatorcontrib><creatorcontrib>Cowan-Jacob, Sandra W.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Tiancen</au><au>Sprague, Elizabeth R.</au><au>Fodor, Michelle</au><au>Stams, Travis</au><au>Clark, Kirk L.</au><au>Cowan-Jacob, Sandra W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of structural biology in medicine illustrated with four case studies</atitle><jtitle>Journal of molecular medicine (Berlin, Germany)</jtitle><stitle>J Mol Med</stitle><addtitle>J Mol Med (Berl)</addtitle><date>2018</date><risdate>2018</risdate><volume>96</volume><issue>1</issue><spage>9</spage><epage>19</epage><pages>9-19</pages><issn>0946-2716</issn><eissn>1432-1440</eissn><abstract>The contributions of structural biology to drug discovery have expanded over the last 20 years from structure-based ligand optimization to a broad range of clinically relevant topics including the understanding of disease, target discovery, screening for new types of ligands, discovery of new modes of action, addressing clinical challenges such as side effects or resistance, and providing data to support drug registration. This expansion of scope is due to breakthroughs in the technology, which allow structural information to be obtained rapidly and for more complex molecular systems, but also due to the combination of different technologies such as X-ray, NMR, and other biophysical methods, which allows one to get a more complete molecular understanding of disease and ways to treat it. In this review, we provide examples of the types of impact molecular structure information can have in the clinic for both low molecular weight and biologic drug discovery and describe several case studies from our own work to illustrate some of these contributions.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>28669027</pmid><doi>10.1007/s00109-017-1565-x</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0946-2716 |
| ispartof | Journal of molecular medicine (Berlin, Germany), 2018, Vol.96 (1), p.9-19 |
| issn | 0946-2716 1432-1440 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1915557099 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Biomedical and Life Sciences Biomedicine Case studies Drug discovery Human Genetics Internal Medicine Low molecular weights Molecular Medicine Molecular structure Molecular weight Optimization Review Side effects |
| title | The impact of structural biology in medicine illustrated with four case studies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A44%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20structural%20biology%20in%20medicine%20illustrated%20with%20four%20case%20studies&rft.jtitle=Journal%20of%20molecular%20medicine%20(Berlin,%20Germany)&rft.au=Hu,%20Tiancen&rft.date=2018&rft.volume=96&rft.issue=1&rft.spage=9&rft.epage=19&rft.pages=9-19&rft.issn=0946-2716&rft.eissn=1432-1440&rft_id=info:doi/10.1007/s00109-017-1565-x&rft_dat=%3Cproquest_cross%3E1983621658%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1983621658&rft_id=info:pmid/28669027&rfr_iscdi=true |